Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases
NCT06411015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 428
Last updated 2024-05-13
Summary
Patients with symptomatic spinal metatstasis will be prosepectively included in a database after theu signes informed consent. Minimally six months after inclusion the survival status is analyzed. These are correlated with factors that are used in an earlier develloped prediction model
Conditions
- Predictive Cancer Model
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-01-01
- Completion
- 2024-05-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
NCT00782691 ·Status: UNKNOWN
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer
NCT03469726 ·Status: UNKNOWN ·Phase: NA
-
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01179360 ·Status: COMPLETED
-
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
NCT07087964 ·Status: RECRUITING
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery
NCT05174026 ·Status: COMPLETED ·Phase: NA
-
Palbociclib and FES PET
NCT02806050 ·Status: COMPLETED ·Phase: PHASE2
-
Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
NCT01291082 ·Status: UNKNOWN
-
Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients
NCT02949154 ·Status: COMPLETED
-
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
NCT05486182 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
NCT04552847 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
NCT03489473 ·Status: UNKNOWN
-
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
NCT01836484 ·Status: COMPLETED
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib
NCT01265979 ·Status: COMPLETED
-
Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer
NCT01591590 ·Status: COMPLETED ·Phase: NA
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
NCT02839291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer
NCT00824213 ·Status: COMPLETED
-
IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)
NCT02228954 ·Status: COMPLETED
-
Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis
NCT02646644 ·Status: COMPLETED
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
NCT02826382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Whole Body DWI to FDG PET
NCT06630845 ·Status: RECRUITING ·Phase: NA